{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:24:54Z","timestamp":1789568694415,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ekir.2018.04.003","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T13:14:05Z","timestamp":1523884445000},"page":"1010-1014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Myelofibrosis-Induced Erythropoietin-Resistant Anemia Due to Severe Refractory Hyperparathyroidism"],"prefix":"10.1016","volume":"3","author":[{"given":"Sidharth Kumar","family":"Sethi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam Bihari","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Wadhwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur","family":"Makasana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Nandwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Raina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2018.04.003_bib1","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2215\/CJN.05420709","article-title":"Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?","volume":"5","author":"Oliveira","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2018.04.003_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/2230-8210.81939","article-title":"Relationship of associated secondary hyperparathyroidism to serum fibroblast growth factor-23 in end stage renal disease: a case-control study","volume":"15","author":"Sliem","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.ekir.2018.04.003_bib3","first-page":"217","article-title":"Systolic function impairment in higher erythropoietin requirement patients in hemodialysis.","volume":"88","author":"Trovato","year":"1997","journal-title":"Recenti Prog Med."},{"key":"10.1016\/j.ekir.2018.04.003_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000044878","article-title":"Red blood cell osmotic fragility in chronically hemodialyzed patients","volume":"78","author":"Wu","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.ekir.2018.04.003_bib5","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1172\/JCI110154","article-title":"Effect of parathyroid hormone on erythropoiesis","volume":"67","author":"Meytes","year":"1981","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ekir.2018.04.003_bib6","first-page":"613","article-title":"High levels of the circulating form of parathyroid hormone do not inhibit in\u00a0vitro erythropoiesis","volume":"102","author":"Delwiche","year":"1983","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.ekir.2018.04.003_bib7","first-page":"1016","article-title":"Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure","volume":"104","author":"McGonigle","year":"1984","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.ekir.2018.04.003_bib8","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ekir.2018.04.003_bib9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/j.ajkd.2017.07.019","article-title":"KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"70","author":"Isakova","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2018.04.003_bib10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/bjh.14774","article-title":"Complete reversal of bone marrow fibrosis after parathyroidectomy for secondary hyperparathyroidism","volume":"178","author":"Azevedo","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ekir.2018.04.003_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJM199301213280304","article-title":"Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia","volume":"328","author":"Rao","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2018.04.003_bib12","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1001\/archinte.1978.03630360038018","article-title":"Anemia and secondary hyperparathyroidism","volume":"138","author":"Zingraff","year":"1978","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ekir.2018.04.003_bib13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archinte.1979.03630450035012","article-title":"Effect of PTx on anemia in chronic renal failure","volume":"139","author":"Barbour","year":"1979","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ekir.2018.04.003_bib14","first-page":"1049","article-title":"Tertiary hyperparathyroidism after renal transplantation: operative indications","volume":"106","author":"D'Alessandro","year":"1989","journal-title":"Surgery"},{"key":"10.1016\/j.ekir.2018.04.003_bib15","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1600-6143.2005.00938.x","article-title":"Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications","volume":"5","author":"Gwinner","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2018.04.003_bib16","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/ndt\/gfh924","article-title":"The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism","volume":"20","author":"Kruse","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2018.04.003_bib17","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1111\/j.1600-6143.2006.01475.x","article-title":"Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet","volume":"6","author":"Leca","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2018.04.003_bib18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/01.tp.0000232452.80018.ad","article-title":"Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism","volume":"82","author":"Szwarc","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2018.04.003_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2215\/CJN.00500705","article-title":"Improvement in hypercalcemia with cinacalcet after kidney transplantation","volume":"1","author":"Srinivas","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2018.04.003_bib20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1159\/000304180","article-title":"Cinacalcet decreases bone formation rate in hypercalcemic hyperparathyroidism after kidney transplantation","volume":"31","author":"Borchhardt","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2018.04.003_bib21","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","article-title":"The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis","volume":"26","author":"Raggi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2018.04.003_bib22","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2018.04.003_bib23","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s00467-011-1829-6","article-title":"CKD-MBD after kidney transplantation","volume":"26","author":"Wesseling-Perry","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2018.04.003_bib24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.mehy.2011.06.030","article-title":"Is secondary hyperparathyroidism-related myelofibrosis a negative prognostic factor for kidney transplant outcome?","volume":"77","author":"Bellavia","year":"2011","journal-title":"Med Hypotheses"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024918300913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024918300913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T07:29:44Z","timestamp":1576135784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024918300913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S2468024918300913"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2018.04.003","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myelofibrosis-Induced Erythropoietin-Resistant Anemia Due to Severe Refractory Hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2018.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}